Document


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
Current Report
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2019 (July 30, 2019)
______________
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware
1-31719
13-4204626
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
______________
200 Oceangate, Suite 100, Long Beach, California 90802
(Address of principal executive offices)
Registrant’s telephone number, including area code: (562) 435-3666
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 Par Value
MOH
New York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicated by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.
 
¨
 





Item 2.02.    Results of Operations and Financial Condition.
On July 30, 2019, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the second quarter ended June 30, 2019, and raising the Company’s full year 2019 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the website cited in the press release is not part of this report.
Note: The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01.    Financial Statements and Exhibits.
(d)     Exhibits:
Exhibit No.
Description
99.1
Press release of Molina Healthcare, Inc., issued July 30, 2019, as to financial results for the second quarter ended June 30, 2019, and raising the Company’s full year 2019 earnings guidance.







SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MOLINA HEALTHCARE, INC.
 
 
 
Date:
July 30, 2019
By:
/s/ Jeff D. Barlow
 
 
 
Jeff D. Barlow
 
 
 
Chief Legal Officer and Secretary







EXHIBIT INDEX
Exhibit No.
Description




Exhibit
https://cdn.kscope.io/614bb5077161772bbc349ea3c848959a-molinaa03a01a01a17.jpg
News Release
Investor Contact: Julie Trudell, Julie.Trudell@molinahealthcare.com, 562-912-6720
Media Contact: Laura Murray, Laura.Murray@molinahealthcare.com, 562-506-9208
____________________________________________________________________________

Molina Healthcare Reports Second Quarter 2019 Financial Results
Raises Full Year 2019 Earnings Guidance

Long Beach, Calif., July 30, 2019 – Molina Healthcare, Inc. (NYSE: MOH) today reported net income for the second quarter of 2019 of $196 million, or $3.06 per diluted share compared to net income of $202 million, or $3.02 per diluted share, in the second quarter of 2018. Financial results for the second quarter of 2019, are summarized below:
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2019
 
2018
 
2019
 
2018
 
(In millions, except per share results)
Premium Revenue

$4,049

 

$4,514

 

$8,001

 

$8,837

Total Revenue

$4,193

 

$4,883

 

$8,312

 

$9,529

Pre-Tax Income

$257

 

$305

 

$517

 

$484

Net Income

$196

 

$202

 

$394

 

$309

EPS - Diluted

$3.06

 

$3.02

 

$6.04

 

$4.68

 
 
 
 
 
 
 
 
MCR
85.6
%
 
85.3
%
 
85.5
%
 
85.7
%
G&A Ratio
7.8
%
 
6.9
%
 
7.6
%
 
7.2
%
Pre-Tax Margin
6.1
%
 
6.2
%
 
6.2
%
 
5.1
%
Effective Tax Rate
24.0
%
 
33.8
%
 
23.9
%
 
36.2
%
After-Tax Margin
4.7
%
 
4.1
%
 
4.7
%
 
3.2
%
Highlights include:
Premium revenue was $4.0 billion in the second quarter of 2019, a 10.3% decrease compared with the second quarter of 2018, which was in line with the Company’s expectations.
Medical care ratio (MCR) was 85.6% in the second quarter of 2019, and 85.3% for the second quarter of 2018.
General and administrative (G&A) expense ratio increased to 7.8% in the second quarter, compared to 6.9% for the second quarter of 2018.
The second quarter results benefited from $12 million, or $0.15 per share, net gain for the repayment of convertible notes and restructuring costs.
After-tax margin was 4.7% for the second quarter of 2019 compared to 4.1% in the second quarter of 2018. Excluding the net gain, after tax margin would have been 4.4% for the second quarter of 2019.
Cash at the parent company amounted to $467 million as of June 30, 2019.
Operating cash flows for the six months ended June 30, 2019, was $156 million.
Raised full year 2019 earnings guidance to $11.20 - $11.50 from $10.50 - $11.00, which does not include any future prior-period reserve development.
“We are very pleased with our strong start to the year, a year in which we intend to demonstrate that we can sustain our attractive margin profile while pivoting to growth,” said Joe Zubretsky, president and CEO. “The business continues to generate significant excess cash flow and our revenue growth initiatives are well under way. Our quarter and year to date results, and the earnings trajectory of our entire portfolio of businesses leading into the second half of the year, give us the confidence to raise full year guidance.”


-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 2
July 30, 2019

Premium Revenue
Premium revenue for the second quarter of 2019 decreased 10.3% to $4.0 billion compared to $4.5 billion in the second quarter of 2018, which was in line with Company expectations.

For the six months ended June 30, 2019, premium revenue decreased 9.5% to $8.0 billion from $8.8 billion for the comparable period in 2018. In both periods, the lower premium revenue is primarily a result of lower Medicaid membership due to the previously announced loss of the New Mexico Medicaid contract, along with the resizing of the Florida Medicaid contract and the related transition out of all but two Florida regions as reported throughout 2018.

Medical Care Ratio
The consolidated MCR for the second quarter of 2019 was 85.6% compared to 85.3% in the second quarter of 2018. Favorable prior period development for the second quarter was $28 million pre-tax.
The MCR for the six months ended June 30, 2019, improved to 85.5% compared to 85.7% for the comparable period in 2018, due to a combination of the following:
The Medicaid MCR improved to 88.3% compared to 90.3% for the six months ended June 30, 2018, primarily due to improvement in the TANF and ABD programs, partially offset by an increased MCR in the Medicaid Expansion program, primarily in California.
The Medicare MCR was relatively stable at 85.0% compared to 84.9% for the six months ended June 30, 2018.
The Marketplace MCR was 64.7% compared to 54.4% for the six months ended June 30, 2018. The prior period was positively impacted by the Cost Sharing Reduction (CSR) reimbursement. In addition, the current year was impacted by a relatively smaller benefit from prior year Marketplace risk adjustment compared to 2018.

General and Administrative Expense Ratio
The general and administrative expenses were 7.8% of total revenues in the second quarter of 2019 compared to 6.9% in the second quarter of 2018.

For the six months ended June 30, 2019, the G&A ratio was 7.6% compared to 7.2% in the comparable prior-year period. In both periods, the year-over-year increases are mainly associated with the decrease in premium revenue.

Interest Expense
The second quarter interest expense was $22 million compared to $32 million in the second quarter of 2018. The decline was due to continued repayment of debt.

Restructuring Costs/Other Income and Expenses
The second quarter results benefited from a $14 million gain on the repayment of convertible notes in the current period, offset somewhat by $2 million in restructuring costs, resulting in a $0.15 net benefit per diluted share.

Balance Sheet
Cash at the parent company amounted to $467 million as of June 30, 2019, compared to $443 million as of March 31, 2019.
During the quarter the Company received $345 million of dividends from the regulated health plan subsidiaries.

-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 3
July 30, 2019

The Company made $139 million in principal repayments on the convertible notes during the quarter and $185 million in repayments since the beginning of the year. The impact of capital deployment actions in the quarter resulted in lower interest expense, a gain on repayment of the convertible notes and a lower share count.

Cash Flow
Operating cash flows for the six months ended June 30, 2019, was $156 million and is lower compared to the six months ended June 30, 2018, primarily due to timing of government payments.

Outlook
The Company raised its full year 2019 earnings guidance range to $11.20 to $11.50 per diluted share, with a midpoint of $11.35, from previously issued guidance of $10.50 to $11.00.
Guidance is based on the following:
Assumes no future restructuring or one-time significant items; and
Assumes no future prior period development.
 
 
July 30, 2019 (1)
 
April 29, 2019 (1)
 
 
(current)
 
(previous)
Premium revenue
 
$16.1B
 
$15.9B
Medicaid
 
$12.3B
 
$12.2B
Medicare
 
$2.2B
 
$2.2B
Marketplace
 
$1.6B
 
$1.5B
Premium tax revenue
 
$450M
 
$425M
Investment income and other revenue
 
$115M
 
$115M
Total revenue
 
$16.7B
 
$16.4B
Medical care costs
 
$13.8B
 
$13.6B
General and administrative expenses
 
$1.3B
 
$1.3B
Premium tax expenses
 
$450M
 
$425M
EBITDA (2)
 
$1,135M - $1,160M
 
$1,080M - $1,120M
Depreciation and amortization
 
$90M
 
$90M
Interest expense and other expenses, net
 
$90M
 
$90M
Income before income taxes
 
$955M - $980M
 
$900M - $940M
Net income
 
$725M - $740M
 
$680M - $710M
Net income per share
 
$11.20 - $11.50
 
$10.50 - $11.00
Diluted weighted average shares
 
64.5M
 
64.7M
 
 
 
 
 
End-of-year membership:
 
 
 
 
Medicaid and Medicare
 
3.1M
 
3.1M
Marketplace
 
270K - 280K
 
270K - 280K
 
 
 
 
 
Operating Statistics:
 
 
 
 
Medical care ratio
 
86%
 
86%
G&A ratio
 
7.7%
 
7.7%
Effective income tax expense rate
 
24.2%
 
24.5%
After-tax margin
 
4.2% - 4.4%
 
4.1% - 4.3%
Medicaid
 
3%
 
3%
Medicare
 
7%
 
6%
Marketplace
 
11%
 
11%
__________________
(1)All amounts are rounded and approximations.
(2)See reconciliation of non-GAAP financial measures at the end of this release.
Conference Call
Management will host a conference call and webcast to discuss Molina Healthcare’s second quarter 2019 results at 8:00 a.m. Eastern time on Wednesday, July 31, 2019. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 0428160. A telephonic replay of the conference call will be available through Wednesday, August 7, 2019, by dialing (877) 344-7529 and entering confirmation number 10132714. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed health care services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 3.4 million members as of June 30, 2019. For more information about Molina Healthcare, please visit molinahealthcare.com.


-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 4
July 30, 2019

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This earnings release contains forward-looking statements regarding the Company’s revised 2019 guidance, as well as its plans, expectations, and anticipated future events. Actual results could differ materially due to numerous known and unknown risks and uncertainties. Those risks and uncertainties are discussed in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and the section entitled “Forward-Looking Statements” in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2019.
These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of July 30, 2019, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statements to conform the statement to actual results or changes in its expectations.



-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 5
July 30, 2019

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2019
 
2018
 
2019
 
2018
 
(In millions, except per-share amounts)
Revenue:
 
 
 
 
 
 
 
Premium revenue
$
4,049

 
$
4,514

 
$
8,001

 
$
8,837

Premium tax revenue
110

 
106

 
248

 
210

Health insurer fees reimbursed

 
104

 

 
165

Service revenue

 
127

 

 
261

Investment income and other revenue
34

 
32

 
63

 
56

Total revenue
4,193

 
4,883

 
8,312

 
9,529

Operating expenses:
 
 
 
 
 
 
 
Medical care costs
3,466

 
3,850

 
6,837

 
7,572

General and administrative expenses
328

 
335

 
630

 
687

Premium tax expenses
110

 
106

 
248

 
210

Health insurer fees

 
99

 

 
174

Depreciation and amortization
22

 
25

 
47

 
51

Restructuring costs
2

 
8

 
5

 
33

Cost of service revenue

 
118

 

 
238

Total operating expenses
3,928

 
4,541

 
7,767

 
8,965

Operating income
265

 
342

 
545

 
564

Other expenses, net:
 
 
 
 
 
 
 
Interest expense
22

 
32

 
45

 
65

Other (income) expenses, net
(14
)
 
5

 
(17
)
 
15

Total other expenses, net
8

 
37

 
28

 
80

Income before income tax expense
257

 
305

 
517

 
484

Income tax expense
61

 
103

 
123

 
175

Net income
$
196

 
$
202

 
$
394

 
$
309

 
 
 
 
 
 
 
 
Net income per share, diluted
$
3.06

 
$
3.02

 
$
6.04

 
$
4.68

 
 
 
 
 
 
 
 
Diluted weighted average shares outstanding
64.0

 
66.7

 
65.1

 
66.0

 
 
 
 
 
 
 
 
Operating Statistics:
 
 
 
 
 
 
 
Medical care ratio
85.6
%
 
85.3
%
 
85.5
%
 
85.7
%
G&A ratio
7.8
%
 
6.9
%
 
7.6
%
 
7.2
%
Premium tax ratio
2.6
%
 
2.3
%
 
3.0
%
 
2.3
%
Effective income tax expense rate
24.0
%
 
33.8
%
 
23.9
%
 
36.2
%
After-tax margin
4.7
%
 
4.1
%
 
4.7
%
 
3.2
%
Medicaid
3.1
%
 
2.3
%
 
3.0
%
 
1.6
%
Medicare
7.1
%
 
5.7
%
 
7.4
%
 
4.9
%
Marketplace
11.2
%
 
16.9
%
 
13.6
%
 
17.4
%



-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 6
July 30, 2019

CONSOLIDATED BALANCE SHEETS
 
June 30,
 
Dec. 31,
 
2019
 
2018
 
Unaudited
 
 
 
(Dollars in millions,
except per-share amounts)
ASSETS
Current assets:
 
 
 
Cash and cash equivalents
$
2,253

 
$
2,826

Investments
2,070

 
1,681

Receivables
1,239

 
1,330

Prepaid expenses and other current assets
132

 
149

Derivative asset
169

 
476

Total current assets
5,863

 
6,462

Property, equipment, and capitalized software, net
373

 
241

Goodwill and intangible assets, net
180

 
190

Restricted investments
98

 
120

Deferred income taxes
70

 
117

Other assets
106

 
24

 
$
6,690

 
$
7,154

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
Medical claims and benefits payable
$
1,767

 
$
1,961

Amounts due government agencies
984

 
967

Accounts payable and accrued liabilities
373

 
390

Deferred revenue
30

 
211

Current portion of long-term debt
65

 
241

Derivative liability
169

 
476

Total current liabilities
3,388

 
4,246

Long-term debt
1,241

 
1,020

Finance lease liabilities
232

 
197

Other long-term liabilities
93

 
44

Total liabilities
4,954

 
5,507

Stockholders’ equity:
 
 
 
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 63 million shares at June 30, 2019 and 62 million shares at December 31, 2018

 

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

 

Additional paid-in capital
240

 
643

Accumulated other comprehensive income (loss)
5

 
(8
)
Retained earnings
1,491

 
1,012

Total stockholders’ equity
1,736

 
1,647

 
$
6,690

 
$
7,154


-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 7
July 30, 2019

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2019
 
2018
 
2019
 
2018
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
Net income
$
196

 
$
202

 
$
394

 
$
309

Adjustments to reconcile net income to net cash (used in) provided by operating activities:
 
 
 
 
 
 
 
Depreciation and amortization
22

 
36

 
47

 
73

Deferred income taxes
4

 

 
19

 
(6
)
Share-based compensation
10

 
7

 
19

 
13

Amortization of convertible senior notes and finance lease liabilities
1

 
6

 
4

 
13

(Gain) loss on debt extinguishment
(14
)
 
5

 
(17
)
 
15

Non-cash restructuring costs

 

 

 
17

Other, net

 
2

 
3

 
4

Changes in operating assets and liabilities:
 
 
 
 
 
 
 
Receivables
120

 
(232
)
 
91

 
(315
)
Prepaid expenses and other current assets
(2
)
 
58

 
18

 
(181
)
Medical claims and benefits payable
(228
)
 
(104
)
 
(194
)
 
(267
)
Amounts due government agencies
52

 
33

 
17

 
205

Accounts payable and accrued liabilities
(31
)
 
30

 
(61
)
 
349

Deferred revenue
(177
)
 
(172
)
 
(181
)
 
(42
)
Income taxes
(46
)
 
49

 
(3
)
 
127

Net cash (used in) provided by operating activities
(93
)
 
(80
)
 
156

 
314

Investing activities:
 
 
 
 
 
 
 
Purchases of investments
(977
)
 
(525
)
 
(1,162
)
 
(914
)
Proceeds from sales and maturities of investments
425

 
792

 
791

 
1,335

Purchases of property, equipment, and capitalized software
(14
)
 
(10
)
 
(20
)
 
(14
)
Other, net
2

 
(4
)
 
(2
)
 
(9
)
Net cash (used in) provided by investing activities
(564
)
 
253

 
(393
)
 
398

Financing activities:
 
 
 
 
 
 
 
Repayment of principal amount of 1.125% Convertible Notes
(139
)
 
(89
)
 
(185
)
 
(89
)
Cash paid for partial settlement of 1.125% Conversion Option
(358
)
 
(134
)
 
(473
)
 
(134
)
Cash received for partial termination of 1.125% Call Option
358

 
134

 
473

 
134

Cash paid for partial termination of 1.125% Warrants
(321
)
 
(113
)
 
(424
)
 
(113
)
Proceeds from borrowings under Term Loan Facility
120

 

 
220

 

Repayment of Credit Facility

 
(300
)
 

 
(300
)
Other, net
26

 
4

 
27

 
(1
)
Net cash used in financing activities
(314
)
 
(498
)
 
(362
)
 
(503
)
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents
(971
)
 
(325
)
 
(599
)
 
209

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period
3,298

 
3,824

 
2,926

 
3,290

Cash, cash equivalents, and restricted cash and cash equivalents at end of period
$
2,327

 
$
3,499

 
$
2,327

 
$
3,499


-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 8
July 30, 2019

HEALTH PLANS SEGMENT MEMBERSHIP
 
June 30,
2019
 
Dec. 31, 2018

June 30,
2018
Ending Membership by Government Program:
 
 
 
 
 
TANF and CHIP
2,008,000

 
2,295,000

 
2,464,000

Medicaid Expansion
595,000

 
660,000

 
675,000

ABD
359,000

 
406,000

 
415,000

Total Medicaid
2,962,000

 
3,361,000

 
3,554,000

MMP - Integrated
57,000

 
54,000

 
55,000

Medicare Special Needs Plans
43,000

 
44,000

 
45,000

Total Medicare
100,000

 
98,000

 
100,000

Total Medicaid and Medicare
3,062,000

 
3,459,000

 
3,654,000

Marketplace
308,000

 
362,000

 
409,000

 
3,370,000

 
3,821,000

 
4,063,000

 
 
 
 
 
 
Ending Membership by Health Plan:
 
 
 
 
 
California
590,000

 
608,000

 
639,000

Florida (1)
142,000

 
313,000

 
398,000

Illinois
221,000

 
224,000

 
219,000

Michigan
360,000

 
383,000

 
397,000

New Mexico (1)
26,000

 
222,000

 
241,000

Ohio
297,000

 
302,000

 
320,000

Puerto Rico
200,000

 
252,000

 
326,000

South Carolina
130,000

 
120,000

 
114,000

Texas
360,000

 
423,000

 
450,000

Washington
811,000

 
781,000

 
776,000

Other (2)
233,000

 
193,000

 
183,000

 
3,370,000

 
3,821,000

 
4,063,000

__________________
(1)
The Company’s Medicaid contracts in New Mexico and in all but two regions in Florida terminated in late 2018 and early 2019. During 2019, the Company continues to serve Medicare and Marketplace members in both Florida and New Mexico, as well as Medicaid members in two regions in Florida.
(2)
“Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.






-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 9
July 30, 2019

UNAUDITED SELECTED FINANCIAL DATA
(In millions, except percentages and per-member per-month amounts)
HEALTH PLANS SEGMENT FINANCIAL DATA — BY GOVERNMENT PROGRAM
 
Member
Months (1)
 
Premium Revenue
 
Medical Care Costs
 
MCR (2)
 
Medical Margin
 
 
Total
 
PMPM
 
Total
 
PMPM
 
 
 
Three Months Ended June 30, 2019
TANF and CHIP
6.1

 
$
1,196

 
$
196.36

 
$
1,048

 
$
172.13

 
87.7
%
 
$
148

Medicaid Expansion
1.8

 
695

 
384.94

 
594

 
328.85

 
85.4

 
101

ABD
1.1

 
1,176

 
1,088.48

 
1,061

 
981.84

 
90.2

 
115

Total Medicaid
9.0

 
3,067

 
341.72

 
2,703

 
301.15

 
88.1

 
364

MMP
0.1

 
406

 
2,421.89

 
356

 
2,118.95

 
87.5

 
50

Medicare
0.2

 
166

 
1,296.99

 
132

 
1,034.43

 
79.8

 
34

Total Medicare
0.3

 
572

 
1,934.17

 
488

 
1,648.73

 
85.2

 
84

Total Medicaid and Medicare
9.3

 
3,639

 
392.52

 
3,191

 
344.14

 
87.7

 
448

Marketplace
0.9

 
410

 
440.20

 
275

 
295.71

 
67.2

 
135

 
10.2

 
$
4,049

 
$
396.87

 
$
3,466

 
$
339.72

 
85.6
%
 
$
583

 
Three Months Ended June 30, 2018
TANF and CHIP
7.5

 
$
1,393

 
$
186.18

 
$
1,205

 
$
161.13

 
86.5
%
 
$
188

Medicaid Expansion
2.1

 
761

 
372.04

 
676

 
330.83

 
88.9

 
85

ABD
1.3

 
1,288

 
1,033.34

 
1,209

 
969.27

 
93.8

 
79

Total Medicaid
10.9

 
3,442

 
319.52

 
3,090

 
286.89

 
89.8

 
352

MMP
0.1

 
367

 
2,224.30

 
313

 
1,893.91

 
85.1

 
54

Medicare
0.2

 
157

 
1,168.40

 
133

 
989.33

 
84.7

 
24

Total Medicare
0.3

 
524

 
1,751.49

 
446

 
1,488.85

 
85.0

 
78

Total Medicaid and Medicare
11.2

 
3,966

 
358.23

 
3,536

 
319.37

 
89.2

 
430

Marketplace
1.2

 
548

 
440.93

 
314

 
253.04

 
57.4

 
234

 
12.4

 
$
4,514

 
$
366.57

 
$
3,850

 
$
312.68

 
85.3
%
 
$
664

 
Six Months Ended June 30, 2019
TANF and CHIP
12.3

 
$
2,369

 
$
192.83

 
$
2,070

 
$
168.56

 
87.4
%
 
$
299

Medicaid Expansion
3.6

 
1,359

 
377.30

 
1,188

 
329.65

 
87.4

 
171

ABD
2.2

 
2,343

 
1,078.40

 
2,103

 
967.59

 
89.7

 
240

Total Medicaid
18.1

 
6,071

 
336.20

 
5,361

 
296.85

 
88.3

 
710

MMP
0.3

 
794

 
2,388.88

 
689

 
2,073.30

 
86.8

 
105

Medicare
0.3

 
329

 
1,290.88

 
265

 
1,041.06

 
80.6

 
64

Total Medicare
0.6

 
1,123

 
1,911.98

 
954

 
1,624.97

 
85.0

 
169

Total Medicaid and Medicare
18.7

 
7,194

 
385.82

 
6,315

 
338.67

 
87.8

 
879

Marketplace
1.9

 
807

 
415.94

 
522

 
269.14

 
64.7

 
285

 
20.6

 
$
8,001

 
$
388.66

 
$
6,837

 
$
332.11

 
85.5
%
 
$
1,164

 
Six Months Ended June 30, 2018
TANF and CHIP
14.9

 
$
2,766

 
$
185.66

 
$
2,477

 
$
166.32

 
89.6
%
 
$
289

Medicaid Expansion
4.1

 
1,513

 
372.39

 
1,317

 
324.19

 
87.1

 
196

ABD
2.5

 
2,542

 
1,023.83

 
2,364

 
951.99

 
93.0

 
178

Total Medicaid
21.5

 
6,821

 
318.11

 
6,158

 
287.22

 
90.3

 
663

MMP
0.3

 
724

 
2,180.86

 
618

 
1,858.87

 
85.2

 
106

Medicare
0.3

 
314

 
1,178.58

 
264

 
992.05

 
84.2

 
50

Total Medicare
0.6

 
1,038

 
1,735.05

 
882

 
1,473.30

 
84.9

 
156

Total Medicaid and Medicare
22.1

 
7,859

 
356.59

 
7,040

 
319.43

 
89.6

 
819

Marketplace
2.6

 
978

 
373.67

 
532

 
203.34

 
54.4

 
446

 
24.7

 
$
8,837

 
$
358.40

 
$
7,572

 
$
307.11

 
85.7
%
 
$
1,265

__________________
(1)
A member month is defined as the aggregate of each month’s ending membership for the period presented.
(2)
The MCR represents medical costs as a percentage of premium revenue.

-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 10
July 30, 2019

HEALTH PLANS SEGMENT FINANCIAL DATA — MEDICAID AND MEDICARE
 
Member
Months
 
Premium Revenue
 
Medical Care Costs
 
MCR
 
Medical Margin
 
 
Total
 
PMPM
 
Total
 
PMPM
 
 
 
Three Months Ended June 30, 2019
California
1.6

 
$
499

 
$
305.40

 
$
415

 
$
253.85

 
83.1
%
 
$
84

Florida
0.3

 
126

 
417.10

 
120

 
399.22

 
95.7

 
6

Illinois
0.6

 
242

 
364.15

 
215

 
323.96

 
89.0

 
27

Michigan
1.1

 
403

 
376.39

 
332

 
310.08

 
82.4

 
71

Ohio
0.9

 
630

 
701.22

 
553

 
615.59

 
87.8

 
77

Puerto Rico
0.6

 
122

 
198.95

 
109

 
177.56

 
89.2

 
13

South Carolina
0.4

 
140

 
362.24

 
125

 
322.55

 
89.0

 
15

Texas
0.7

 
598

 
916.74

 
551

 
844.02

 
92.1

 
47

Washington
2.4

 
611

 
257.79

 
535

 
225.67

 
87.5

 
76

Other (1) (2)
0.7

 
268

 
394.85

 
236

 
347.43

 
88.0

 
32

 
9.3

 
$
3,639

 
$
392.52

 
$
3,191

 
$
344.14

 
87.7
%
 
$
448

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2018
California
1.8

 
$
517

 
$
289.80

 
$
441

 
$
247.36

 
85.4
%
 
$
76

Florida
1.2

 
377

 
353.81

 
362

 
339.31

 
95.9

 
15

Illinois
0.6

 
203

 
311.60

 
170

 
261.59

 
84.0

 
33

Michigan
1.2

 
388

 
342.45

 
331

 
292.20

 
85.3

 
57

New Mexico (2)
0.7

 
313

 
469.88

 
290

 
435.36

 
92.7

 
23

Ohio
1.0

 
535

 
571.08

 
482

 
514.57

 
90.1

 
53

Puerto Rico
0.9

 
184

 
188.26

 
165

 
168.20

 
89.3

 
19

South Carolina
0.4

 
123

 
350.22

 
107

 
304.20

 
86.9

 
16

Texas
0.7

 
576

 
835.66

 
510

 
740.55

 
88.6

 
66

Washington
2.2

 
571

 
252.61

 
526

 
232.49

 
92.0

 
45

Other (1)
0.5

 
179

 
322.99

 
152

 
274.59

 
85.0

 
27

 
11.2

 
$
3,966

 
$
358.23

 
$
3,536

 
$
319.37

 
89.2
%
 
$
430

 
Six Months Ended June 30, 2019
California
3.3

 
$
998

 
$
302.59

 
$
863

 
$
261.66

 
86.5
%
 
$
135

Florida
0.7

 
288

 
399.86

 
247

 
343.24

 
85.8

 
41

Illinois
1.3

 
469

 
356.16

 
400

 
303.50

 
85.2

 
69

Michigan
2.2

 
798

 
369.66

 
658

 
305.00

 
82.5

 
140

Ohio
1.8

 
1,220

 
680.20

 
1,090

 
607.85

 
89.4

 
130

Puerto Rico
1.2

 
224

 
181.91

 
199

 
161.40

 
88.7

 
25

South Carolina
0.8

 
276

 
362.68

 
240

 
315.84

 
87.1

 
36

Texas
1.3

 
1,197

 
909.59

 
1,083

 
822.59

 
90.4

 
114

Washington
4.8

 
1,225

 
258.10

 
1,121

 
236.19

 
91.5

 
104

Other (1) (2)
1.3

 
499

 
383.07

 
414

 
317.56

 
82.9

 
85

 
18.7

 
$
7,194

 
$
385.82

 
$
6,315

 
$
338.67

 
87.8
%
 
$
879

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2018
California
3.6

 
$
1,011

 
$
281.14

 
$
853

 
$
237.26

 
84.4
%
 
$
158

Florida
2.2

 
759

 
352.68

 
707

 
328.26

 
93.1

 
52

Illinois
1.1

 
344

 
305.94

 
292

 
259.87

 
84.9

 
52

Michigan
2.3

 
764

 
339.56

 
662

 
294.19

 
86.6

 
102

New Mexico
1.4

 
632

 
468.00

 
600

 
444.44

 
95.0

 
32

Ohio
1.9

 
1,086

 
573.87

 
942

 
497.75

 
86.7

 
144

Puerto Rico
1.9

 
370

 
190.68

 
339

 
174.74

 
91.6

 
31

South Carolina
0.7

 
245

 
349.15

 
211

 
300.87

 
86.2

 
34

Texas
1.4

 
1,138

 
822.72

 
1,029

 
744.05

 
90.4

 
109

Washington
4.5

 
1,155

 
254.64

 
1,100

 
242.48

 
95.2

 
55

Other (1)
1.1

 
355

 
318.94

 
305

 
273.97

 
85.9

 
50

 
22.1

 
$
7,859

 
$
356.59

 
$
7,040

 
$
319.43

 
89.6
%
 
$
819

__________________
(1)
“Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.
(2)
In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 11
July 30, 2019

HEALTH PLANS SEGMENT FINANCIAL DATA — MARKETPLACE
 
Member
Months
 
Premium Revenue
 
Medical Care Costs
 
MCR
 
Medical Margin
 
 
Total
 
PMPM
 
Total
 
PMPM
 
 
 
Three Months Ended June 30, 2019
California
0.2

 
$
61

 
$
382.22

 
$
35

 
$
220.31

 
57.6
%
 
$
26

Florida
0.1

 
50

 
390.03

 
30

 
236.50

 
60.6

 
20

Michigan

 
10

 
521.67

 
6

 
308.37

 
59.1

 
4

Ohio
0.1

 
24

 
754.67

 
19

 
565.69

 
75.0

 
5

Texas
0.3

 
167

 
379.29

 
117

 
267.12

 
70.4

 
50

Washington
0.1

 
51

 
803.11

 
35

 
548.48

 
68.3

 
16

Other (1)
0.1

 
47

 
527.41

 
33

 
376.04

 
71.3

 
14

 
0.9

 
$
410

 
$
440.20

 
$
275

 
$
295.71

 
67.2
%
 
$
135

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2018
California
0.2

 
$
73

 
$
426.16

 
$
21

 
$
117.92

 
27.7
%
 
$
52

Florida
0.1

 
100

 
698.31

 
38

 
269.86

 
38.6

 
62

Michigan

 
15

 
288.67

 
7

 
146.97

 
50.9

 
8

New Mexico

 
31

 
418.82

 
18

 
247.06

 
59.0

 
13

Ohio

 
31

 
518.64

 
23

 
381.46

 
73.6

 
8

Texas
0.7

 
222

 
330.12

 
160

 
238.72

 
72.3

 
62

Washington
0.2

 
56

 
787.80

 
41

 
572.48

 
72.7

 
15

Other (2)

 
20

 
NM

 
6

 
NM

 
NM

 
14

 
1.2

 
$
548

 
$
440.93

 
$
314

 
$
253.04

 
57.4
%
 
$
234

 
Six Months Ended June 30, 2019
California
0.3

 
$
117

 
$
361.73

 
$
68

 
$
210.71

 
58.2
%
 
$
49

Florida
0.3

 
111

 
406.52

 
56

 
205.17

 
50.5

 
55

Michigan

 
20

 
492.23

 
11

 
255.98

 
52.0

 
9

Ohio
0.1

 
54

 
805.96

 
34

 
505.10

 
62.7

 
20

Texas
0.9

 
315

 
341.18

 
226

 
245.82

 
72.0

 
89

Washington
0.1

 
98

 
756.26

 
64

 
490.84

 
64.9

 
34

Other (1)
0.2

 
92

 
501.13

 
63

 
344.61

 
68.8

 
29

 
1.9

 
$
807

 
$
415.94

 
$
522

 
$
269.14

 
64.7
%
 
$
285

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2018
California
0.4

 
$
122

 
$
334.47

 
$
52

 
$
141.73

 
42.4
%
 
$
70

Florida
0.3

 
145

 
468.36

 
22

 
73.13

 
15.6

 
123

Michigan
0.1

 
28

 
254.69

 
16

 
145.49

 
57.1

 
12

New Mexico
0.1

 
65

 
429.19

 
37

 
246.77

 
57.5

 
28

Ohio
0.1

 
57

 
458.48

 
40

 
319.53

 
69.7

 
17

Texas
1.4

 
451

 
318.93

 
306

 
216.83

 
68.0

 
145

Washington
0.2

 
95

 
653.89

 
71

 
486.90

 
74.5

 
24

Other (2)

 
15

 
NM

 
(12
)
 
NM

 
NM

 
27

 
2.6

 
$
978

 
$
373.67

 
$
532

 
$
203.34

 
54.4
%
 
$
446

__________________
(1)
“Other” includes the New Mexico, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results in 2019.
(2)
“Other” includes the Utah and Wisconsin health plans, where the Company did not participate in the Marketplace in 2018. Therefore, the ratios for 2018 periods are not meaningful (NM).






-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 12
July 30, 2019

HEALTH PLANS SEGMENT FINANCIAL DATA — TOTAL
 
Member
Months
 
Premium Revenue
 
Medical Care Costs
 
MCR
 
Medical Margin
 
 
Total
 
PMPM
 
Total
 
PMPM
 
 
 
Three Months Ended June 30, 2019
California
1.8

 
$
560

 
$
312.21

 
$
450

 
$
250.87

 
80.4
%
 
$
110

Florida
0.4

 
176

 
408.99

 
150

 
350.47

 
85.7

 
26

Illinois
0.6

 
242

 
364.15

 
215

 
323.96

 
89.0

 
27

Michigan
1.1

 
413

 
378.86

 
338

 
310.05

 
81.8

 
75

Ohio
1.0

 
654

 
703.09

 
572

 
613.85

 
87.3

 
82

Puerto Rico
0.6

 
122

 
198.95

 
109

 
177.56

 
89.2

 
13

South Carolina
0.4

 
140

 
362.24

 
125

 
322.55

 
89.0

 
15

Texas
1.0

 
765

 
700.15

 
668

 
611.53

 
87.3

 
97

Washington
2.5

 
662

 
271.96

 
570

 
234.05

 
86.1

 
92

Other (1) (2)
0.8

 
315

 
410.27

 
269

 
350.76

 
85.5

 
46

 
10.2

 
$
4,049

 
$
396.87

 
$
3,466

 
$
339.72

 
85.6
%
 
$
583

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2018
California
2.0

 
$
590

 
$
301.73

 
$
462

 
$
236.04

 
78.2
%
 
$
128

Florida
1.3

 
477

 
394.38

 
400

 
331.13

 
84.0

 
77

Illinois
0.6

 
203

 
311.60

 
170

 
261.59

 
84.0

 
33

Michigan
1.2

 
403

 
340.08

 
338

 
285.78

 
84.0

 
65

New Mexico (2)
0.7

 
344

 
464.90

 
308

 
416.99

 
89.7

 
36

Ohio
1.0

 
566

 
567.96

 
505

 
506.66

 
89.2

 
61

Puerto Rico
0.9

 
184

 
188.26

 
165

 
168.20

 
89.3

 
19

South Carolina
0.4

 
123

 
350.22

 
107

 
304.20

 
86.9

 
16

Texas
1.4

 
798

 
585.50

 
670

 
492.23

 
84.1

 
128

Washington
2.4

 
627

 
268.84

 
567

 
242.80

 
90.3

 
60

Other (1)
0.5

 
199

 
360.90

 
158

 
285.65

 
79.1

 
41

 
12.4

 
$
4,514

 
$
366.57

 
$
3,850

 
$
312.68

 
85.3
%
 
$
664

 
Six Months Ended June 30, 2019
California
3.6

 
$
1,115

 
$
307.88

 
$
931

 
$
257.10

 
83.5
%
 
$
184

Florida
1.0

 
399

 
401.69

 
303

 
305.23

 
76.0

 
96

Illinois
1.3

 
469

 
356.16

 
400

 
303.50

 
85.2

 
69

Michigan
2.2

 
818

 
371.91

 
669

 
304.10

 
81.8

 
149

Ohio
1.9

 
1,274

 
684.77

 
1,124

 
604.12

 
88.2

 
150

Puerto Rico
1.2

 
224

 
181.91

 
199

 
161.40

 
88.7

 
25

South Carolina
0.8

 
276

 
362.68

 
240

 
315.84

 
87.1

 
36

Texas
2.2

 
1,512

 
675.34

 
1,309

 
584.90

 
86.6

 
203

Washington
4.9

 
1,323

 
271.34

 
1,185

 
242.96

 
89.5

 
138

Other
1.5

 
591

 
397.61

 
477

 
320.90

 
80.7

 
114

 
20.6

 
$
8,001

 
$
388.66

 
$
6,837

 
$
332.11

 
85.5
%
 
$
1,164

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2018
California
4.0

 
$
1,133

 
$
286.07

 
$
905

 
$
228.44

 
79.9
%
 
$
228

Florida
2.5

 
904

 
367.18

 
729

 
296.29

 
80.7

 
175

Illinois
1.1

 
344

 
305.94

 
292

 
259.87

 
84.9

 
52

Michigan
2.4

 
792

 
335.59

 
678

 
287.23

 
85.6

 
114

New Mexico
1.5

 
697

 
464.11

 
637

 
424.58

 
91.5

 
60

Ohio
2.0

 
1,143

 
566.77

 
982

 
486.79

 
85.9

 
161

Puerto Rico
1.9

 
370

 
190.68

 
339

 
174.74

 
91.6

 
31

South Carolina
0.7

 
245

 
349.15

 
211

 
300.87

 
86.2

 
34

Texas
2.8

 
1,589

 
567.95

 
1,335

 
477.43

 
84.1

 
254

Washington
4.7

 
1,250

 
267.01

 
1,171

 
250.05

 
93.6

 
79

Other
1.1

 
370

 
333.35

 
293

 
263.24

 
79.0

 
77

 
24.7

 
$
8,837

 
$
358.40

 
$
7,572

 
$
307.11

 
85.7
%
 
$
1,265

__________________
(1)
“Other” includes the Idaho, Mississippi, New York, Utah and Wisconsin health plans, which are not individually significant to the Company’s consolidated operating results.
(2)
In 2019, “Other” includes the New Mexico health plan. The New Mexico health plan’s Medicaid contract terminated on December 31, 2018, and therefore its 2019 results are not individually significant to the Company’s consolidated operating results.

-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 13
July 30, 2019

SELECTED FINANCIAL DATA

The following table provides details of the Company’s medical care costs for the periods indicated:
 
Three Months Ended June 30,
 
2019
 
2018
 
Amount
 
PMPM
 
% of
Total
 
Amount
 
PMPM
 
% of
Total
Fee for service
$
2,594

 
$
254.36

 
74.8
%
 
$
2,861

 
$
232.40

 
74.4
%
Pharmacy
429

 
42.06

 
12.4

 
567

 
46.05

 
14.7

Capitation
288

 
28.17

 
8.3

 
282

 
22.89

 
7.3

Other
155

 
15.13

 
4.5

 
140

 
11.34

 
3.6

 
$
3,466

 
$
339.72

 
100.0
%
 
$
3,850

 
$
312.68

 
100.0
%
 
Six Months Ended June 30,
 
2019
 
2018
 
Amount
 
PMPM
 
% of
Total
 
Amount
 
PMPM
 
% of
Total
Fee for service
$
5,108

 
$
248.18

 
74.7
%
 
$
5,606

 
$
227.38

 
74.1
%
Pharmacy
842

 
40.88

 
12.3

 
1,150

 
46.66

 
15.2

Capitation
573

 
27.81

 
8.4

 
594

 
24.09

 
7.8

Other
314

 
15.24

 
4.6

 
222

 
8.98

 
2.9

 
$
6,837

 
$
332.11

 
100.0
%
 
$
7,572

 
$
307.11

 
100.0
%

The following table provides details of the Company’s medical claims and benefits payable as of the dates indicated:
 
June 30,
 
Dec. 31,
 
2019
 
2018
Fee-for-service claims incurred but not paid (IBNP)
$
1,346

 
$
1,562

Pharmacy payable
117

 
115

Capitation payable
63

 
52

Other (1)
241

 
232

 
$
1,767

 
$
1,961

______________________
(1)
“Other” medical claims and benefits payable include amounts payable to certain providers for which the Company acts as an intermediary on behalf of various state agencies without assuming financial risk. Such receipts and payments do not impact the Company’s consolidated statements of income. As of June 30, 2019 and December 31, 2018, the Company had recorded non-risk provider payables of approximately $112 million and $107 million, respectively.


-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 14
July 30, 2019

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)


The Company’s claims liability includes a provision for adverse claims deviation based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior period” represent the amount by which the original estimate of claims and benefits payable at the beginning of the period was more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:
 
Six Months Ended
 
Year Ended
 
June 30,
 
Dec. 31, 2018
 
2019
 
2018
 
Medical claims and benefits payable, beginning balance
$
1,961

 
$
2,192

 
$
2,192

Components of medical care costs related to:
 
 
 
 
 
Current period
7,069

 
7,870

 
15,478

Prior period (1)
(232
)
 
(298
)
 
(341
)
Total medical care costs
6,837

 
7,572

 
15,137

Change in non-risk and other provider payables
4

 
56

 
13

Payments for medical care costs related to:
 
 
 
 
 
Current period
5,585

 
6,248

 
13,671

Prior period
1,450

 
1,652

 
1,710

Total paid
7,035

 
7,900

 
15,381

Medical claims and benefits payable, ending balance
$
1,767

 
$
1,920

 
$
1,961

 
 
 
 
 
 
Days in claims payable, fee for service (2)
48

 
49

 
53

______________________
(1)
The June 30, 2018, amount includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $76 million. December 31, 2018, includes the 2018 benefit of the 2017 Marketplace CSR reimbursement of $81 million.
(2)
Claims payable includes primarily IBNP. It also includes certain fee-for-service payables reported in “Other” medical claims and benefits payable amounting to $35 million, $33 million and $43 million, as of June 30, 2019, June 30, 2018, and December 31, 2018, respectively.



-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 15
July 30, 2019

SUMMARY OF NON-RUN RATE ITEMS AFFECTING CURRENT QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
(In millions, except per diluted share amounts)

The table below summarizes the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations. The individual items presented below increase (decrease) income before income tax expense.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
Amount
 
Per Diluted Share (1)
 
Amount
 
Per Diluted Share (1)
 
Amount
 
Per Diluted Share (1)
 
Amount
 
Per Diluted Share (1)
Restructuring costs
$
(2
)
 
$
(0.02
)
 
$
(8
)
 
$
(0.10
)
 
$
(5
)
 
$
(0.05
)
 
(33
)
 
(0.39
)
Gain (loss) on debt extinguishment
14

 
0.17

 
(5
)
 
(0.06
)
 
17

 
0.21

 
(15
)
 
(0.21
)
 
$
12

 
$
0.15

 
$
(13
)
 
$
(0.16
)
 
$
12

 
$
0.16

 
$
(48
)
 
$
(0.60
)
______________________
(1)
Except for permanent differences between GAAP and tax (such as certain expenses that are not deductible for tax purposes), per diluted share amounts are generally calculated at the statutory income tax rate of 22.6% and 22% for 2019 and 2018, respectively.

NON-GAAP FINANCIAL MEASURES

The Company uses non-generally accepted accounting principles, or non-GAAP, financial measures as supplemental metrics in evaluating the Company’s financial performance, making financing and business decisions, and forecasting and planning for future periods. For these reasons, management believes such measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. These non-GAAP financial measures should be considered as supplements to, and not as substitutes for or superior to, GAAP measures. See further information regarding non-GAAP measures below the tables.
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2019
 
2018
 
2019
 
2018
Net income
$
196

 
$
202

 
$
394

 
$
309

Adjustments:
 
 
 
 


 


Depreciation, and amortization of intangible assets and capitalized software
22

 
33

 
47

 
67

Interest expense
22

 
32

 
45

 
65

Income tax expense
61

 
103

 
123

 
175

EBITDA
$
301

 
$
370

 
$
609

 
$
616

Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:
Earnings before interest, taxes, depreciation and amortization (“EBITDA”): Net income on a GAAP basis less depreciation, and amortization of intangible assets and capitalized software, interest expense and income tax expense. The Company believes that EBITDA is helpful in assessing the Company’s ability to meet the cash demands of its operating units.

-MORE-


Molina Healthcare, Inc. Announces Second Quarter 2019 Results
Page 16
July 30, 2019

NON-GAAP FINANCIAL MEASURES (CONTINUED)
 
Three Months Ended June 30,
 
Six Months Ended June 30,
2019
 
2018
 
2019
 
2018
 
 
 
Amount
 
Per Diluted Share
 
Amount
 
Per Diluted Share
 
Amount
 
Per Diluted Share
 
Amount
 
Per Diluted Share
Net income
$
196

 
$
3.06

 
$
202

 
$
3.02

 
$
394

 
$
6.04

 
$
309

 
$
4.68

Adjustment:
 
 
 
 
 
 
 
 
 
 


 


 


Amortization of intangible assets
4

 
0.07

 
5

 
0.08

 
9

 
0.14

 
10

 
0.16

Income tax effect (1)
(1
)
 
(0.02
)
 
(1
)
 
(0.02
)
 
(2
)
 
(0.03
)
 
(2
)
 
(0.04
)
Amortization of intangible assets, net of tax effect
3

 
0.05

 
4

 
0.06

 
7

 
0.11

 
8

 
0.12

Adjusted net income
$
199

 
$
3.11

 
$
206

 
$
3.08

 
$
401

 
$
6.15

 
$
317

 
$
4.80

________________________
(1)
Income tax effect of adjustments calculated at the blended federal and state statutory tax rate of 22.6% and 22% for 2019 and 2018, respectively.
Adjustments made to GAAP measures used to calculate the non-GAAP measures used in this news release follow:
Adjusted net income: Net income on a GAAP basis less amortization of intangible assets, net of income tax effect calculated at the statutory tax rate. The Company believes that adjusted net income is helpful in assessing the Company’s financial performance exclusive of the non-cash impact of the amortization of purchased intangibles.
Adjusted net income per diluted share: Adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.


2019 REVISED GUIDANCE

Reconciliation of Non-GAAP Financial Measures
 
Low End
 
High End
 
(In millions)
Net income
$
725

 
$
740

Adjustments:
 
 
 
Depreciation, and amortization of intangible assets and capitalized software
90

 
90

Interest expense
90

 
90

Income tax expense
230

 
240

EBITDA
$
1,135

 
$
1,160




-END-